NRT Prescription Training

Purpose: The training's purpose is to teach clinicians about the medications available to help patients quit tobacco — how they work, how to select and dose them based on a patient's level of nicotine dependence, and how to manage side effects, combination regimens, and relapse. It's meant to move providers beyond behavioral counseling alone into the pharmacologic side of treatment.

Content: The training opens by introducing the two broad categories of tobacco cessation medications: nicotine replacement therapy (NRT) and non-nicotine pharmacotherapy. It then details the specific forms of NRT — nicotine gum, patch, lozenge, nasal spray, and inhaler — describing how each delivers nicotine (through the mouth lining, skin, nose, or oral mucosa) and their available dosages.

Before prescribing, the training teaches how to assess a patient's level of nicotine dependence, opening with a brainstorming prompt on why this assessment matters. It presents two assessment tools: the Fagerström Test for Nicotine Dependence, a short standardized six-item questionnaire (covering things like time to first cigarette, difficulty refraining in restricted settings, and cigarettes per day) that produces a 0–10 score classifying dependence from "very low" to "very high," with high/very high scores indicating a candidate for NRT; and the simpler Heaviness of Smoking Index, which uses just two questions (cigarettes per day and time to first cigarette) to classify patients into low, moderate, or high addiction categories.

The training then moves into detailed recommendations for using NRT, including non-nicotine therapy (bupropion), the nicotine patch, and combination therapy — noting that NRT is typically started on the quit date and continued for 8–12 weeks. It provides detailed guidelines for the nicotine patch specifically: dosing tied to cigarettes-per-day, a tapering schedule after 4–8 weeks of abstinence, and common side effects like skin irritation and sleep disturbance. A dedicated slide (credited to the "Rx for Change" curriculum from UC, USC, and Western University of Health Sciences) walks through the patch's advantages (steady nicotine levels, ease of use, fewer compliance issues) and disadvantages (inability to titrate dose, allergic reactions, potential morning cravings or sleep disruption, and unsuitability for patients with certain skin conditions).

Combination NRT is covered in depth — pairing a long-acting patch with a short-acting form (gum, lozenge, inhaler, or spray) to manage both baseline levels and breakthrough cravings — along with combining NRT with bupropion SR. The slides cite several clinical trials and meta-analyses on the comparative effectiveness and safety of these combinations (Silagy et al. 2004, Jorenby 1999, Simon et al. 2004, Bars et al. 2006), as well as a note that combining varenicline with NRT or bupropion has not been well established and may increase side effects and treatment discontinuation (citing a small 2006 Pfizer-sponsored study). A related slide addresses bupropion's specific safety considerations, including seizure risk and how its side-effect profile (more insomnia) compares to the nicotine patch (more vivid dreams and skin reactions).

The final third of the training addresses relapse prevention: congratulating success, discussing benefits and barriers with patients, framing relapse as a normal part of the chronic nature of nicotine dependence rather than a personal failure, encouraging wellness/lifestyle changes and ongoing social support (including Nicotine Anonymous and follow-up), and helping patients identify personal triggers and high-risk situations (e.g., alcohol use, a smoking spouse, pregnancy, weight gain) to build an individualized prevention plan. The training closes with a dedicated section on post-cessation weight gain, acknowledging it's a common and likely (though typically modest, under 10 lbs) side effect of quitting, and recommending that clinicians address it directly — encouraging patients to focus on cessation first and weight management later, promoting healthy diet and exercise, and considering bupropion SR or nicotine gum, both shown to delay (though not prevent) weight gain.